Bailard, Inc. Stryker Corp Transaction History

Bailard, Inc.

$3.8 Billion
Q3 2024

A detailed history of Bailard, Inc. transactions in Stryker Corp stock. As of the latest transaction made, Bailard, Inc. holds 25,484 shares of SYK stock, worth $9.93 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

25,484

Previous 25,264 0.87%

Holding current value

$9.93 Million

Previous $8.6 Million 7.08%

% of portfolio

0.24%

Previous 0.24%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$315.94 - $371.96 $69,506 - $81,831	220 Added 0.87%	25,484 $9.21 Million
Q2 2024 Jul 25, 2024	BUY	$324.3 - $354.67 $4.59 Million - $5.02 Million	14,157 Added 127.46%	25,264 $8.6 Million
Q1 2024 May 08, 2024	BUY	$293.94 - $358.71 $3,527 - $4,304	12 Added 0.11%	11,107 $3.97 Million
Q4 2023 Feb 02, 2024	SELL	$253.85 - $299.46 $86,816 - $102,415	-342 Reduced 2.99%	11,095 $3.32 Million
Q3 2023 Oct 24, 2023	BUY	$266.54 - $302.43 $610,643 - $692,867	2,291 Added 25.05%	11,437 $3.13 Million
Q2 2023 Jul 20, 2023	SELL	$271.49 - $305.09 $49,139 - $55,221	-181 Reduced 1.94%	9,146 $2.79 Million
Q1 2023 May 08, 2023	SELL	$246.13 - $285.47 $54,886 - $63,659	-223 Reduced 2.34%	9,327 $2.66 Million
Q4 2022 Feb 02, 2023	BUY	$205.51 - $253.93 $114,469 - $141,439	557 Added 6.19%	9,550 $2.33 Million
Q3 2022 Oct 18, 2022	BUY	$189.27 - $231.83 $8,517 - $10,432	45 Added 0.5%	8,993 $1.82 Million
Q2 2022 Jul 27, 2022	BUY	$194.09 - $276.37 $2,134 - $3,040	11 Added 0.12%	8,948 $1.78 Million
Q1 2022 Apr 25, 2022	SELL	$245.33 - $277.77 $43,914 - $49,720	-179 Reduced 1.96%	8,937 $2.39 Million
Q4 2021 Feb 10, 2022	SELL	$236.63 - $276.44 $36,677 - $42,848	-155 Reduced 1.67%	9,116 $2.44 Million
Q3 2021 Nov 15, 2021	SELL	$248.9 - $280.09 $3,484 - $3,921	-14 Reduced 0.15%	9,271 $2.45 Million
Q2 2021 Aug 13, 2021	BUY	$242.95 - $267.0 $60,251 - $66,216	248 Added 2.74%	9,285 $2.41 Million
Q1 2021 May 13, 2021	BUY	$221.01 - $248.82 $173,713 - $195,572	786 Added 9.53%	9,037 $2.2 Million
Q4 2020 Feb 03, 2021	SELL	$202.01 - $245.04 $209,484 - $254,106	-1,037 Reduced 11.16%	8,251 $2.02 Million
Q3 2020 Nov 10, 2020	BUY	$177.77 - $215.81 $110,572 - $134,233	622 Added 7.18%	9,288 $1.94 Million
Q2 2020 Aug 12, 2020	BUY	$144.67 - $207.03 $25,317 - $36,230	175 Added 2.06%	8,666 $1.56 Million
Q1 2020 Apr 16, 2020	SELL	$126.5 - $225.1 $88,929 - $158,245	-703 Reduced 7.65%	8,491 $1.41 Million
Q4 2019 Jan 31, 2020	SELL	$197.98 - $220.53 $12,868 - $14,334	-65 Reduced 0.7%	9,194 $1.93 Million
Q3 2019 Oct 18, 2019	BUY	$205.4 - $221.82 $8,216 - $8,872	40 Added 0.43%	9,259 $2 Million
Q2 2019 Jul 26, 2019	BUY	$180.24 - $205.58 $10,273 - $11,718	57 Added 0.62%	9,219 $1.9 Million
Q1 2019 Apr 24, 2019	SELL	$152.46 - $198.0 $31,711 - $41,184	-208 Reduced 2.22%	9,162 $1.81 Million
Q4 2018 Feb 05, 2019	SELL	$145.0 - $178.65 $189,805 - $233,852	-1,309 Reduced 12.26%	9,370 $1.47 Million
Q3 2018 Nov 13, 2018	BUY	$163.25 - $177.68 $33,303 - $36,246	204 Added 1.95%	10,679 $1.9 Million
Q2 2018 Aug 08, 2018	BUY	$155.17 - $179.78 $30,723 - $35,596	198 Added 1.93%	10,475 $1.77 Million
Q1 2018 May 07, 2018	BUY	$148.01 - $168.91 $119,148 - $135,972	805 Added 8.5%	10,277 $1.65 Million
Q4 2017 Feb 08, 2018	SELL	$143.51 - $159.74 $3.72 Million - $4.15 Million	-25,949 Reduced 73.26%	9,472 $0
Q3 2017 Oct 11, 2017	BUY	$138.36 - $147.87 $210,583 - $225,058	1,522 Added 4.49%	35,421 $5.03 Million
Q2 2017 Aug 11, 2017	SELL	N/A	-7,839 Reduced 18.78%	33,899 $0
Q1 2017 Jan 29, 2018	SELL	N/A	-1,208 Reduced 2.81%	41,738 $5.5 Million
Q4 2016 Jan 29, 2018	BUY	N/A	19 Added 0.04%	42,946 $0
Q3 2016 Jan 29, 2018	BUY	N/A	19,197 Added 80.9%	42,927 $5 Million
Q2 2016 Jan 29, 2018	BUY	N/A	23,730	23,730 $0

Others Institutions Holding SYK

# of Institutions

2,230

Shares Held

285M

Call Options Held

1.35M

Put Options Held

1.6M

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $147B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.

Account